A phase and frequency alignment protocol for 1H MRSI data of the prostate

NMR in Biomedicine

Volumn 25, Issue 5, 2012, Pages 755-765

  Wright, Alan J ^a   Buydens, Lutgarde M C ^b   Heerschap, Arend ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

MRSI; NMR signal processing; Peak alignment; Prostate cancer

Indexed keywords

ALIGNMENT ALGORITHMS; AUTOMATIC ALIGNMENT; CROSS CORRELATIONS; DATA SETS; FIRST PRINCIPAL COMPONENTS; FREQUENCY VARIATION; IN-PHASE; LOCALISATION; MEDIAN VALUE; METABOLITE LEVEL; MRSI; NMR SIGNALS; PHASE CORRECTION ALGORITHM; PHYSIOLOGICAL CONDITION; POLYAMINES; PROSTATE CANCERS; SENSITIVE METHOD; SIMULATED DATA; SPATIAL FIELDS; STANDARD DEVIATION; STATISTICAL PATTERN RECOGNITION; THREE PARAMETERS;

ALGORITHMS; BIOMOLECULES; DISEASES; FREQUENCY STANDARDS; METABOLITES; PATTERN RECOGNITION; RESONANCE; SIGNAL PROCESSING; STATISTICS; UROLOGY;

ALIGNMENT;

CHOLINE; CITRIC ACID; CREATINE;

ALGORITHM; ARTICLE; CONTROLLED STUDY; HUMAN; MALE; PEAK ALIGNMENT ALGORITHM; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; SIMULATION;

ALGORITHMS; CHOLINE; CITRIC ACID; COMPUTER SIMULATION; CREATINE; DATABASES, FACTUAL; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MODELS, BIOLOGICAL; PATTERN RECOGNITION, AUTOMATED; POLYAMINES; PRINCIPAL COMPONENT ANALYSIS; PROSTATIC NEOPLASMS; SIGNAL PROCESSING, COMPUTER-ASSISTED; SIGNAL-TO-NOISE RATIO;

EID: 84859649200     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1790     Document Type: Article

References (31)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 2010; 60(5): 277-300.
2. Ahmed HU, Kirkham A, Arya M, Illing R, Freeman A, Allen C, Emberton M. Is it time to consider a role for MRI before prostate biopsy? Nat. Rev. 2009; 6(4): 197-206.
3. Futterer JJ, Barentsz JO, Heijmink SW. Value of 3-T magnetic resonance imaging in local staging of prostate cancer. Top. Magn. Reson. Imaging 2008; 19(6): 285-289.
4. Villers A, Lemaitre L, Haffner J, Puech P. Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance. Curr. Opin. Urol. 2009; 19(3): 274-282.
5. Mueller-Lisse UG, Scherr MK. Proton MR spectroscopy of the prostate. Eur. J. Radiol. 2007; 63(3): 351-360.
6. Nayyar R, Kumar R, Kumar V, Jagannathan NR, Gupta NP, Hemal AK. Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer. BJU Int. 2009; 103(12): 1614-1620.
7. 1H magnetic resonance spectroscopy of prostate cancer: biomarkers for tumor characterization. Cancer Biomark. 2008; 4(4-5): 263-276.
8. Shukla-Dave A, Hricak H, Moskowitz C, Ishill N, Akin O, Kuroiwa K, Spector J, Kumar M, Reuter VE, Koutcher JA, Zakian KL. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. Radiology 2007; 245(2): 499-506.
9. Laudadio T, Pels P, De Lathauwer L, Van Hecke P, Van Huffel S. Tissue segmentation and classification of MRSI data using canonical correlation analysis. Magn. Reson. Med. 2005; 54(6): 1519-1529.
10. Kelm BM, Menze BH, Zechmann CM, Baudendistel KT, Hamprecht FA. Automated estimation of tumor probability in prostate magnetic resonance spectroscopic imaging: pattern recognition vs quantification. Magn. Reson. Med. 2007; 57(1): 150-159.
11. Provencher SW. Estimation of metabolite concentrations from localized invivo proton NMR spectra. Magn. Reson. Med. 1993; 30(6): 672-679.
12. Ratiney H, Sdika M, Coenradie Y, Cavassila S, van Ormondt D, Graveron-Demilly D. Time-domain semi-parametric estimation based on a metabolite basis set. NMR Biomed. 2005; 18(1): 1-13.
13. Forshed J, Schuppe-Koistinen I, Jacobsson SP. Peak alignment of NMR signals by means of a genetic algorithm. Anal. Chim. Acta 2003; 487(2): 189-199.
14. Veselkov KA, Lindon JC, Ebbels TM, Crockford D, Volynkin VV, Holmes E, Davies DB, Nicholson JK. Recursive segment-wise peak alignment of biological (1)H NMR spectra for improved metabolic biomarker recovery. Anal. Chem. 2009; 81(1): 56-66.
15. Wu W, Daszykowski M, Walczak B, Sweatman BC, Connor SC, Haselden JN, Crowther DJ, Gill RW, Lutz MW. Peak alignment of urine NMR spectra using fuzzy warping. J. Chem. Inform. Model. 2006; 46(2): 863-875.
16. Zhao Q, Stoyanova R, Du S, Sajda P, Brown TR. HiRes - a tool for comprehensive assessment and interpretation of metabolomic data. Bioinformatics 2006; 22(20): 2562-2564.
17. Forshed J, Torgrip RJ, Aberg KM, Karlberg B, Lindberg J, Jacobsson SP. A comparison of methods for alignment of NMR peaks in the context of cluster analysis. J. Pharm. Biomed. Anal. 2005; 38(5): 824-832.
18. Van Huffel S, Wang Y, Vanhamme L, Van Hecke P. Automatic frequency alignment and quantitation of single resonances in multiple magnetic resonance spectra via complex principal component analysis. J. Magn. Reson. 2002; 158(1-2): 1-14.
19. Zhu XP, Young K, Ebel A, Soher BJ, Kaiser L, Matson G, Weiner WM, Schuff N. Robust analysis of short echo time (1)H MRSI of human brain. Magn. Reson. Med. 2006; 55(3): 706-711.
20. Brown TR, Stoyanova R. NMR spectral quantitation by principal-component analysis. II. Determination of frequency and phase shifts. J. Magn. Reson. 1996; 112(1): 32-43.
21. Stoyanova R, Brown TR. NMR spectral quantitation by principal component analysis. III. A generalized procedure for determination of lineshape variations. J. Magn. Reson. 2002; 154(2): 163-175.
22. Witjes H, Melssen WJ, in't Zandt HJ, van der Graaf M, Heerschap A, Buydens LM. Automatic correction for phase shifts, frequency shifts, and lineshape distortions across a series of single resonance lines in large spectral data sets. J. Magn. Reson. 2000; 144(1): 35-44.
23. Stoyanova R, Nicholls AW, Nicholson JK, Lindon JC, Brown TR. Automatic alignment of individual peaks in large high-resolution spectral data sets. J. Magn. Reson. 2004; 170(2): 329-335.
24. van der Graaf M, Heerschap A. Effect of cation binding on the proton chemical shifts and the spin-spin coupling constant of citrate. J. Magn. Reson. 1996; 112(1): 58-62.
25. Mescher M, Tannus A, Johnson MO, Garwood M. Solvent suppression using selective echo dephasing. J. Magn. Reson. Ser. A 1996; 123(2): 226-229.
26. Scheenen TW, Klomp DW, Roll SA, Futterer JJ, Barentsz JO, Heerschap A. Fast acquisition-weighted three-dimensional proton MR spectroscopic imaging of the human prostate. Magn. Reson. Med. 2004; 52(1): 80-88.
27. Scheenen TW, Heijmink SW, Roell SA, H-V de Kaa CA, Knipscheer BC, Witjes JA, Barentsz JO, Heerschap A. Three-dimensional proton MR spectroscopy of human prostate at 3T without endorectal coil: feasibility. Radiology 2007; 245(2): 507-516.
28. Spectral Database for Organic Compounds. SDBSWeb: National Institute of Advanced Industrial Science and Technology: Tsukuba. [Accessed on 1 March 2006]
29. 13C inverse 2D method for the analysis of the polyamines putrescine, spermidine and spermine in cell extracts and biofluids. NMR Biomed. 1998; 11(2): 47-54.
30. 1H-MR spectroscopic imaging of the human prostate at 3T. Magn. Reson. Med. 2005; 53(6): 1268-1274.
31. Giskeodegard GF, Bloemberg TG, Postma G, Sitter B, Tessem MB, Gribbestad IS, Bathen TF, Buydens LM. Alignment of high resolution magic angle spinning magnetic resonance spectra using warping methods. Anal. Chim. Acta 2010; 683(1): 1-11.